The detection of prostate cancer is complex and it is recognised that PSA-screening can result in over-diagnosis; we therefore performed a subgroup analysis in which studies based on PSA-screening were meta-analysed separately from those in which cancers were clinically detected. The gene discussed is KLK3; the disease is cancer.